Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

96.33EUR
11:35am EDT
Price Change (% chg)

€1.45 (+1.53%)
Prev Close
€96.88
Open
€94.53
Day's High
€97.15
Day's Low
€94.53
Volume
389,935
Avg. Vol
415,113
52-wk High
€100.10
52-wk Low
€81.83

FREG.DE

Chart for FREG.DE

About

Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments... (more)

Overall

Beta: 0.46
Market Cap (Mil.): €16,929.72
Shares Outstanding (Mil.): 178.43
Dividend: 1.10
Yield (%): 1.16

Financials

  FREG.DE Industry Sector
P/E (TTM): 18.41 66.39 37.76
EPS (TTM): 5.15 -- --
ROI: 9.22 4.99 18.76
ROE: 12.67 9.80 19.59
Search Stocks

UPDATE 1-Fresenius hikes profit outlook on strong hospitals unit

* FMC unit Q2 net misses market view on U.S. healthcare cuts (Adds background on hospitals business, FMC unit results)

30 Jul 2013

Rhoen-Klinikum shareholder files case against AGM vote

FRANKFURT - B. Braun Holding, an investor in Rhoen-Klinikum , said it had filed a case on Tuesday contesting a shareholder vote to remove a barrier to the German hospital operator being taken over.

09 Jul 2013

UPDATE 1-China probes pricing at drugmakers including GSK, Merck

* Top agency to review costs, prices at dozens of drugmakers

04 Jul 2013

Falls at Fresenius and Danone push back Europe shares

LONDON, July 2 - Medical group Fresenius and food group Danone weighed on European shares on Tuesday, with traders expecting little near-term progress for European equities.

02 Jul 2013

Falls at Fresenius, Danone weigh on Europe shares

LONDON, July 2 - Falls at medical group Fresenius and food group Danone weighed on European shares on Tuesday, with traders expecting the near-term trend for European equities to remain a relatively negative one.

02 Jul 2013

Fresenius sells biotech unit

FRANKFURT, June 28 - Germany's Fresenius said it has sold its biotechnology business to the owners of Neopharm, Israel's second largest pharma company, as it focuses on the other parts of its business that it sees as offering better opportunities.

28 Jun 2013

RPT-Fitch Affirms Fresenius at 'BB+'; Outlook Revised to Positive

June 17 - (The following statement was released by the rating agency)

17 Jun 2013

Rhoen says renewed takeover attempt not a given

FRANKFURT, June 13 - Rhoen-Klinikum cautioned that a shareholder vote that removed a major barrier against a takeover of the German hospital operator would not necessarily lead to a new bid from one-time suitor Fresenius .

13 Jun 2013

UPDATE 1-Rhoen shareholders vote to scrap takeover hurdle

* Removal of hurdle could lure back one-time bidder Fresenius

12 Jun 2013

Fresenius eyes more hospital deals in Germany

FRANKFURT, May 17 - German diversified healthcare group Fresenius will look for further takeovers to underpin its position as Germany's largest private-sector hospitals operator, its chief executive said.

17 May 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: Wright Reports
$495.00
Provider: Datamonitor
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks